Eris Lifesciences Ltd
NSE:ERIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eris Lifesciences Ltd
NSE:ERIS
|
IN |
|
M
|
Myrexis Inc
OTC:MYRX
|
US |
Wall Street
Price Targets
ERIS Price Targets Summary
Eris Lifesciences Ltd
According to Wall Street analysts, the average 1-year price target for
ERIS
is 1 789.9 INR
with a low forecast of 1 535.2 INR and a high forecast of 2 037 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ERIS's stock price target?
Price Target
1 789.9
INR
According to Wall Street analysts, the average 1-year price target for
ERIS
is 1 789.9 INR
with a low forecast of 1 535.2 INR and a high forecast of 2 037 INR.
What is Eris Lifesciences Ltd's Revenue forecast?
Projected CAGR
14%
For the last 12 years the
compound annual growth rate for
Eris Lifesciences Ltd's revenue is
18%.
The projected
CAGR
for the next 3 years is
14%.
What is Eris Lifesciences Ltd's Operating Income forecast?
Projected CAGR
22%
For the last 12 years the
compound annual growth rate for
Eris Lifesciences Ltd's operating income is
20%.
The projected
CAGR
for the next 3 years is
22%.
What is Eris Lifesciences Ltd's Net Income forecast?
Projected CAGR
37%
For the last 12 years the
compound annual growth rate for
Eris Lifesciences Ltd's net income is
16%.
The projected
CAGR
for the next 3 years is
37%.
